Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,927 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk factors for non-diabetic renal disease in diabetic patients.
Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Robles NR, Agraz I, Poch E, Rodas L, Lozano V, Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García N, Goicoechea M, Calero F, Bonet J, Galceran JM, Liaño F, Pascual J, Praga M, Fulladosa X, Soler MJ. Bermejo S, et al. Among authors: diaz m. Clin Kidney J. 2020 Jan 3;13(3):380-388. doi: 10.1093/ckj/sfz177. eCollection 2020 Jun. Clin Kidney J. 2020. PMID: 32699618 Free PMC article.
Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
Cruzado JM, Poveda R, Ibernón M, Díaz M, Fulladosa X, Carrera M, Torras J, Bestard O, Navarro I, Ballarín J, Romero R, Grinyó JM. Cruzado JM, et al. Among authors: diaz m. Nephrol Dial Transplant. 2011 Nov;26(11):3596-602. doi: 10.1093/ndt/gfr072. Epub 2011 Mar 10. Nephrol Dial Transplant. 2011. PMID: 21393611 Clinical Trial.
Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation.
Marco H, Mirapeix E, Arcos E, Comas J, Ara J, Gil-Vernet S, Puig J, Vinyas O, Perello M, Oppenheimer F, Poveda R, Ibernón M, Díaz M, Ballarin J; Catalan Study Group of Glomerular Diseases (GLOMCAT). Marco H, et al. Among authors: diaz m. Clin Transplant. 2013 May-Jun;27(3):338-47. doi: 10.1111/ctr.12084. Epub 2013 Feb 20. Clin Transplant. 2013. PMID: 23421384
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
Rabasco C, Cavero T, Román E, Rojas-Rivera J, Olea T, Espinosa M, Cabello V, Fernández-Juarez G, González F, Ávila A, Baltar JM, Díaz M, Alegre R, Elías S, Antón M, Frutos MA, Pobes A, Blasco M, Martín F, Bernis C, Macías M, Barroso S, de Lorenzo A, Ariceta G, López-Mendoza M, Rivas B, López-Revuelta K, Campistol JM, Mendizábal S, de Córdoba SR, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Rabasco C, et al. Among authors: diaz m. Kidney Int. 2015 Nov;88(5):1153-60. doi: 10.1038/ki.2015.227. Epub 2015 Jul 29. Kidney Int. 2015. PMID: 26221755 Free article.
Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis.
Fernandez-Juarez G, Villacorta J, Ruiz-Roso G, Panizo N, Martinez-Marín I, Marco H, Arrizabalaga P, Díaz M, Perez-Gómez V, Vaca M, Rodríguez E, Cobelo C, Fernandez L, Avila A, Praga M, Quereda C, Ortiz A. Fernandez-Juarez G, et al. Among authors: diaz m. Clin Kidney J. 2016 Jun;9(3):381-6. doi: 10.1093/ckj/sfw028. Epub 2016 May 24. Clin Kidney J. 2016. PMID: 27274821 Free PMC article.
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G, Rojas-Rivera J, Logt AV, Justino J, Sevillano A, Caravaca-Fontán F, Ávila A, Rabasco C, Cabello V, Varela A, Díez M, Martín-Reyes G, Diezhandino MG, Quintana LF, Agraz I, Gómez-Martino JR, Cao M, Rodríguez-Moreno A, Rivas B, Galeano C, Bonet J, Romera A, Shabaka A, Plaisier E, Espinosa M, Egido J, Segarra A, Lambeau G, Ronco P, Wetzels J, Praga M; STARMEN Investigators. Fernández-Juárez G, et al. Kidney Int. 2021 Apr;99(4):986-998. doi: 10.1016/j.kint.2020.10.014. Epub 2020 Nov 7. Kidney Int. 2021. PMID: 33166580 Free article. Clinical Trial.
The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes.
Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Robles NR, Agraz I, Poch E, Rodas L, Lozano V, Fernández-Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García-Fernández N, Goicoechea M, Calero F, Bonet J, Liaño F, Pascual J, Bestard O, Praga M, Fulladosa X, Soler MJ. Bermejo S, et al. Among authors: diaz m. Clin Kidney J. 2023 Jul 6;16(10):1656-1663. doi: 10.1093/ckj/sfad142. eCollection 2023 Oct. Clin Kidney J. 2023. PMID: 37779839 Free PMC article.
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.
Vincenti F, Fervenza FC, Campbell KN, Diaz M, Gesualdo L, Nelson P, Praga M, Radhakrishnan J, Sellin L, Singh A, Thornley-Brown D, Veronese FV, Accomando B, Engstrand S, Ledbetter S, Lin J, Neylan J, Tumlin J; Focal Segmental Glomerulosclerosis Study Group. Vincenti F, et al. Among authors: diaz m. Kidney Int Rep. 2017 Apr 7;2(5):800-810. doi: 10.1016/j.ekir.2017.03.011. eCollection 2017 Sep. Kidney Int Rep. 2017. PMID: 29270487 Free PMC article.
3,927 results